Richard A. Young
Massachusetts Institute of Technology · Biology
Active 1956–2024
Research topics
- Biology
- Genetics
- Computational biology
- Computer Science
- Medicine
- Cell biology
- Internal medicine
- Biophysics
- Virology
- Physics
Selected publications
MeCP2 links heterochromatin condensates and neurodevelopmental disease
Nature · 2020 · 200 citations
Senior authorCorresponding- Biology
- Genetics
RNA-Mediated Feedback Control of Transcriptional Condensates
Cell · 2020 · 614 citations
Senior authorCorresponding- Biology
- Cell biology
- Biophysics
Partitioning of cancer therapeutics in nuclear condensates
Science · 2020 · 517 citations
Senior authorCorresponding- Computer Science
- Computer Science
- Computational biology
The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical properties. Here, we investigated whether condensates concentrate small-molecule cancer therapeutics such that their pharmacodynamic properties are altered. We found that antineoplastic drugs become concentrated in specific protein condensates in vitro and that this occurs through physicochemical properties independent of the drug target. This behavior was also observed in tumor cells, where drug partitioning influenced drug activity. Altering the properties of the condensate was found to affect the concentration and activity of drugs. These results suggest that selective partitioning and concentration of small molecules within condensates contributes to drug pharmacodynamics and that further understanding of this phenomenon may facilitate advances in disease therapy.
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 69 citations
- Biology
- Computational biology
- Genetics
Prolonged SARS-CoV-2 RNA shedding and recurrence of PCR-positive tests have been widely reported in patients after recovery, yet these patients most commonly are non-infectious. Here we investigated the possibility that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the human genome and that transcription of the integrated sequences might account for PCR-positive tests. In support of this hypothesis, we found chimeric transcripts consisting of viral fused to cellular sequences in published data sets of SARS-CoV-2 infected cultured cells and primary cells of patients, consistent with the transcription of viral sequences integrated into the genome. To experimentally corroborate the possibility of viral retro-integration, we describe evidence that SARS-CoV-2 RNAs can be reverse transcribed in human cells by reverse transcriptase (RT) from LINE-1 elements or by HIV-1 RT, and that these DNA sequences can be integrated into the cell genome and subsequently be transcribed. Human endogenous LINE-1 expression was induced upon SARS-CoV-2 infection or by cytokine exposure in cultured cells, suggesting a molecular mechanism for SARS-CoV-2 retro-integration in patients. This novel feature of SARS-CoV-2 infection may explain why patients can continue to produce viral RNA after recovery and suggests a new aspect of RNA virus replication.
Recent grants
NIH · $4.0M · 2015
NIH · $2.9M · 2003
NIH · $488k · 2014
NIH · $665k · 2007
NIH · $3.1M · 2015
Frequent coauthors
- 187 shared
Brian J. Abraham
- 132 shared
Leonard I. Zon
Boston Children's Museum
- 124 shared
Tong Ihn Lee
Whitehead Institute for Biomedical Research
- 113 shared
Rudolf Jaenisch
Whitehead Institute for Biomedical Research
- 100 shared
A. Thomas Look
Dana-Farber Cancer Institute
- 95 shared
Nathanael S. Gray
Dana-Farber Cancer Institute
- 82 shared
Nicholas Kwiatkowski
- 78 shared
Nancy M. Hannett
Whitehead Institute for Biomedical Research
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Richard A. Young
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup